Literature DB >> 26349570

Rhinocerebral Mucormycosis Among Diabetic Patients: An Emerging Trend.

Sujatha S Reddy1, N Rakesh2, Pallavi Chauhan3, Shivani Sharma2.   

Abstract

Mucormycosis is an acute necrotic fungal infection with a fulminant course. Earlier considered a rare entity, mucormycosis is being reported with increasing frequency in recent years, possibly due to the increase in immunocompromised population especially diabetic patients. We report three cases of rhinocerebral mucormycosis among poorly controlled diabetic patients. This article emphasizes the need for further awareness of this disease, early diagnosis, and treatment to counter this opportunistic infection.

Entities:  

Keywords:  Diabetes mellitus; Fungal infection; Immunocompromised status; Indian population; Palatal necrosis; Rhinocerebral mucormycosis

Mesh:

Year:  2015        PMID: 26349570     DOI: 10.1007/s11046-015-9934-x

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  39 in total

Review 1.  Gastrointestinal basidiobolomycosis in Arizona: clinical and epidemiological characteristics and review of the literature.

Authors:  G M Lyon; J D Smilack; K K Komatsu; T M Pasha; J A Leighton; J Guarner; T V Colby; M D Lindsley; M Phelan; D W Warnock; R A Hajjeh
Journal:  Clin Infect Dis       Date:  2001-04-20       Impact factor: 9.079

2.  Rhinofacial Conidiobolus coronatus infection presenting with nasal enlargement.

Authors:  N Fischer; Ch Ruef; C Ebnöther; E B Bächli
Journal:  Infection       Date:  2008-11-08       Impact factor: 3.553

Review 3.  Pulmonary mucormycosis: results of medical and surgical therapy.

Authors:  M Tedder; J A Spratt; M P Anstadt; S S Hegde; S D Tedder; J E Lowe
Journal:  Ann Thorac Surg       Date:  1994-04       Impact factor: 4.330

4.  Opportunistic mycelial fungal infections in organ transplant recipients: emerging importance of non-Aspergillus mycelial fungi.

Authors:  Shahid Husain; Barbara D Alexander; Patricia Munoz; Robin K Avery; Sally Houston; Timothy Pruett; Richard Jacobs; Edward A Dominguez; Jan G Tollemar; Katherine Baumgarten; Chen M Yu; Marilyn M Wagener; Peter Linden; Shimon Kusne; Nina Singh
Journal:  Clin Infect Dis       Date:  2003-07-09       Impact factor: 9.079

Review 5.  Treatment of zygomycosis: current and new options.

Authors:  Thomas R Rogers
Journal:  J Antimicrob Chemother       Date:  2008-01       Impact factor: 5.790

Review 6.  Zygomycosis.

Authors:  Corina E Gonzalez; Michael G Rinaldi; Alan M Sugar
Journal:  Infect Dis Clin North Am       Date:  2002-12       Impact factor: 5.982

7.  Rhino-orbito-cerebral mucormycosis. A retrospective analysis of clinical features and treatment outcomes.

Authors:  Suneetha Nithyanandam; Moire S Jacob; Ravindra R Battu; Reji K Thomas; Majorie A Correa; Ophelia D'Souza
Journal:  Indian J Ophthalmol       Date:  2003-09       Impact factor: 1.848

Review 8.  Mucormycosis and entomophthoramycosis: a review of the clinical manifestations, diagnosis and treatment.

Authors:  R M Prabhu; R Patel
Journal:  Clin Microbiol Infect       Date:  2004-03       Impact factor: 8.067

9.  Pulmonary mucormycosis caused by Cunninghamella elegans in a patient with chronic myelogenous leukemia.

Authors:  K J Kwon-Chung; R C Young; M Orlando
Journal:  Am J Clin Pathol       Date:  1975-10       Impact factor: 2.493

10.  A fatal pseudo-tumour: disseminated basidiobolomycosis.

Authors:  Guido E L van den Berk; L Arnold Noorduyn; Ruud J van Ketel; Jeannouel van Leeuwen; Willem A Bemelman; Jan M Prins
Journal:  BMC Infect Dis       Date:  2006-09-15       Impact factor: 3.090

View more
  2 in total

1.  Rhinocerebral Mucormycosis: Report of a Rare Case.

Authors:  Richa Sahota; Ramandeep Gambhir; Samir Anand; Avani Dixit
Journal:  Ethiop J Health Sci       Date:  2017-01

2.  Mucormycosis of jaws - literature review and current treatment protocols.

Authors:  Hitesh Dewan; Hiren Patel; Haren Pandya; Bijal Bhavsar; Urvi Shah; Surya Singh
Journal:  Natl J Maxillofac Surg       Date:  2022-06-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.